ArticleCell reports2022
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2.
Caitlin M Rodriguez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it
ArticleCell reports2022
Caitlin M Rodriguez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.